Skinny Bee Diet capsules, 500 mg, packaged in a 60-count bottle
Published December 28, 2016 · Recall initiated: October 28, 2016
Summary
FDA records drug Class I recall D-0223-2017, published December 28, 2016 and initiated October 28, 2016. Recalling firm: Love My Tru Body; Status: Terminated; Reported quantity: 74 bottles; Lot: Bottles stamped MFD: 03.07.2016 EXP: 03.06.2018. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without an approved NDA/ANDA: presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and phenolphthalein.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Love My Tru Body
- Distributor
- Nationwide
- Lot
- Bottles stamped MFD: 03.07.2016 EXP: 03.06.2018
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDA3rd DEGREE capsules, 60-count bottles, Manufactured for: Making it A Lifestyle, L.L.C.December 28, 2016
- FDADuloxetine Delayed-release Capsules USP 30 mg 30-count bottles, Rx Only, Manufactured by: Inventia HealthcareDecember 28, 2016
- FDABLACK GOLD X ADVANCED capsules, 60-count bottles, Manufactured for: Making it A Lifestyle, L.L.C.December 28, 2016
- FDAToms of Maine Naturally Dry Natural Powder Antiperspirant Stick, Distributed by: Tom's of Maine, Kennebunk,December 28, 2016
- FDABLACK LABEL X capsules, 60-count bottles, Manufactured for: Making it A Lifestyle, L.L.C.December 28, 2016
- FDAAMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For IntravenousDecember 28, 2016
Questions about this recall
Was Skinny Bee Diet capsules, 500 mg, packaged in a 60-count bottle recalled?
Yes. FDA published recall D-0223-2017 on December 28, 2016. Reported hazard: Marketed without an approved NDA/ANDA: presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and phenolphthalein.
What should I do if I have this product?
Voluntary: Firm initiated · Letter